Asciminib for chronic myeloid leukaemia after two or more tyrosine kinase inhibitors

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 3 Aug 2022

Cite this